VMAT2 dysfunction impairs vesicular dopamine uptake, driving its oxidation and α-synuclein pathology in DJ-1–linked Parkinson’s neurons
Authors:
- Leonie M. HegerLHLeonie M. Heger
- Francesco GubinelliFGFrancesco Gubinelli
- Aida Cardona-AlberichACAida Cardona-Alberich
- Matteo RovereMRMatteo Rovere
- Ulf MattiUMUlf Matti
- Stephan A. MüllerSMStephan A. Müller
- Lena JaschkowitzLJLena Jaschkowitz
- Martina SchiffererMSMartina Schifferer
- Wolfgang WurstWWWolfgang Wurst
- Stefan F. LichtenthalerSLStefan F. Lichtenthaler
Open Access
- 13 February 2026
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (7) , eadz5645
Abstract
Parkinson’s disease (PD) is characterized by α-synuclein accumulation and dopaminergic neuron degeneration, with dopamine (DA) oxidation emerging as a key pathological driver. However, the mechanisms underlying this neurotoxic process remain unclear. Using PD patient-derived and CRISPR-engineered induced pluripotent stem cell midbrain dopaminergic neurons lacking DJ-1, we identified defective sequestration of cytosolic DA into synaptic vesicles, which culminated in DA oxidation and α-synuclein pathology. In-depth proteomics, state-of-the-art imaging, and ultrasensitive DA probes uncovered that decreased vesicular monoamine transporter 2 (VMAT2) protein and function impaired vesicular DA uptake, resulting in reduced vesicle availability and abnormal vesicle morphology. Furthermore, VMAT2 activity and vesicle endocytosis are processes dependent on adenosine 5′-triphosphate (ATP), which is notably reduced in DJ-1–deficient dopaminergic neurons. ATP supplementation restored vesicular function and alleviated DA-related pathologies in mutant dopaminergic neurons. This study reveals an ATP-sensitive mechanism that regulates DA homeostasis through VMAT2 and vesicle dynamics in midbrain dopaminergic neurons, highlighting enhanced DA sequestration as a promising therapeutic strategy for PD.Keywords
All Related Versions
Funding Information
- Helmholtz Association (ExNet-0041-Phase2-3 (‘SyNergy-HMGU’))
- Hector Fellow Academy
- European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (948027)
- Germany’s Excellence Strategy within the framework of the Munich Cluster of Systems Neurology (EXC 2145 SyNergy—ID 390857198)
- Germany’s Excellence Strategy within the framework of the Munich Cluster of Systems Neurology (EXC 2145 SyNergy—ID 390857198)
- Germany’s Excellence Strategy within the framework of the Munich Cluster of Systems Neurology (EXC 2145 SyNergy—ID 390857198)
- Rise up! programme of the Boehringer Ingelheim Foundation
- DFG, Heisenberg programme (447395247)
- Bundesministerium für Bildung und Forschung under the aegis of JPND (01ED2402A)
- Helmholtz AssociationGermany’s Excellence Strategy within the framework of the Munich Cluster of Systems Neurology (EXC 2145 SyNergy—ID 390857198)
This publication has 100 references indexed in Scilit:
- Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesiclesProceedings of the National Academy of Sciences, 2000
- Synaptic Vesicle Transporter Expression Regulates Vesicle Phenotype and Quantal SizeJournal of Neuroscience, 2000
- Intraneuronal dopamine-quinone synthesis: A reviewNeurotoxicity Research, 1999
- Tyrosine Hydroxylase Is Inactivated by Catechol‐Quinones and Converted to a Redox‐Cycling QuinoproteinJournal of Neurochemistry, 1999
- VMAT2 knockout mice: Heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicityProceedings of the National Academy of Sciences, 1997
- Loss of dopaminergic neurons in parkinsonism: possible role of reactive dopamine metabolites1997
- Essential functions of synapsins I and II in synaptic vesicle regulationNature, 1995
- Rab3C is a synaptic vesicle protein that dissociates from synaptic vesicles after stimulation of exocytosisJournal of Biological Chemistry, 1994
- Functional Identification and Molecular Cloning of a Human Brain Vesicle Monoamine TransporterJournal of Neurochemistry, 1993
- Does ATP cross the cell plasma membrane.1982